SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

CVS Q3 Adjusted EPS $2.09 vs. IBES Estimate $1.65

CVS reported third-quarter adjusted EPS of $2.09, compared with the IBES estimate of $1.65.

CVS
SquawkNews Desk 2 updates Updated Nov 04, 2026, 11:34 AM UTC

Story updates

11:32:52 AM UTC
SquawkNews
Nov 04 (Reuters) - CVS Q3 EPS USD 1.68.
11:34:23 AM UTC
SquawkNews
BRIEF-CVS Q3 Adjusted EPS USD 2.09 Vs. IBES Estimate USD 1.65 Nov 04 (Reuters) - CVS Q3 EPS USD 1.68

Related stories

Nooks Secures $500M and Launches AI Sales Assistant Node M impact | EQUITY | Nov 04, 2026, 01:55 PM UTC Insulet Q3 Net Income Rises, Issues FY26 Outlook Insulet reported third-quarter net income of $141.1 million, or $2.03 per diluted share, versus $87.6 million, or $1.24 per share, a year earlier. Adjusted net income rose 57.2% to M impact | EARNINGS | Nov 04, 2026, 01:54 PM UTC Kansai Nerolac Reports September-Quarter Consolidated Net Profit of 1.46 Billion Rupees M impact | EARNINGS | Nov 04, 2026, 01:54 PM UTC Cenovus Sees 2026 Capex at Top End or Slightly Above $5B-$5.3B Range M impact | EARNINGS | Nov 04, 2026, 01:52 PM UTC Novo Nordisk Raises 2026 Outlook as Wegovy Pill Rollout Speeds Up Novo Nordisk raised its 2026 outlook and is speeding up the rollout of its Wegovy pill, according to the headline. M impact | EARNINGS | Nov 04, 2026, 01:52 PM UTC Grønlandsbanken Reports Higher Nine-Month Pretax Profit Grønlandsbanken reported higher pretax profit for the first nine months of 2026. L impact | EARNINGS | Nov 04, 2026, 01:52 PM UTC